Click 'Attend' above to register.

Feedyard veterinarians are tasked with selecting a metaphylaxis antimicrobial approved to control bovine respiratory disease (BRD) in high-risk animals. Often overlooked as a criterion for metaphylaxis selection is the rate of first-treatment success after an initial BRD episode occurring subsequent to the post-metaphylactic interval (PMI).

A pivotal factor determining profit or loss is the ability for metaphylactically managed cattle to favorably respond to initial BRD treatment and rejoin penmates at the bunk. BRD re-treats and chronics can quickly elevate production costs and drain profit potential.

The webinar will review studies examining first-treatment success following metaphylaxis, and help control BRD in high-risk stocker and feedlot cattle. Also learn about solutions that you can implement when antibiotics fail to meet expectations.

What you will learn:

  1. Examine first-treatment success following metaphylaxis to help control BRD in high-risk stocker and feedlot cattle.
  2. Review 12 studies showing how metaphylactically managed cattle respond to initial BRD treatment and quickly rejoin penmates.
  3. Select a metaphylaxis product to help reduce medical expenses, performance losses and input costs associated with recurring BRD to optimize profit potential.
  4. Discover solutions that can be implemented when antibiotics fail to meet expectations.

Who should attend:

  • Feedlot veterinarians
  • Stocker veterinarians
  • Nutritionists